@article{006a9ca833eb4b4f8a7da3a780fb5fdb,
title = "20th international conference on emerging infectious diseases in the pacific rim organized by the United States-Japan cooperative medical sciences program (USJCMSP)",
abstract = "The 20th International Conference on Emerging Infectious Diseases in the Pacific Rim to3ok place in Shenzhen, China on January 8–9, 2018 followed by meetings of the acquired immunodeficiency syndrome (AIDS)/immunology, acute respiratory infections, cancer, hepatitis, and viral diseases panels on January 10–11. The conference was organized as part of the United States-Japan Cooperative Medical Sciences Program (USJCMSP) by the Japan Agency for Medical Research and Development (AMED) and the U.S. National Institutes of Health (NIH) and was locally hosted by the Shenzhen Third People{\textquoteright}s Hospital and the Chinese Academy of Sciences (CAS) Institute of Microbiology. The conference provides the basis for networking and fostering of collaboration opportunities between researchers in Southeast Asia and the United States based on the scientific and interactive platform of the USJCMSP and takes place in the region on an annual basis. This report summarizes the discussions and conclusions from the conference.",
keywords = "Merging infectious diseases, Pacific rim",
author = "{USJCMSP AIDS, ARI, Cancer, Hepatitis, Immunology and Viral Diseases Panels} and Bernabe, {K. Gayle} and Lu, {Kristina T.} and Handley, {F. Gray} and Griffin, {Diane E.} and Ichiro Kurane and Aikichi Iwamoto and Gao, {George F.} and Florian Krammer",
note = "Funding Information: Funding: The conference series is supported by the Japan Agency for Medical Research and Development, the Ministry of Foreign Affairs; the Ministry of Health, Labour, and Welfare; and the Ministry of Education, Culture, Sports, Science, and Technology and the United States National Institutes of Health. Funding Information: Abstract: The 20th International Conference on Emerging Infectious Diseases in the Pacific Rim to3ok place in Shenzhen, China on January 8–9, 2018 followed by meetings of the acquired immunodeficiency syndrome (AIDS)/immunology, acute respiratory infections, cancer, hepatitis, and viral diseases panels on January 10–11. The conference was organized as part of the United States-Japan Cooperative Medical Sciences Program (USJCMSP) by the Japan Agency for Medical Research and Development (AMED) and the U.S. National Institutes of Health (NIH) and was locally hosted by the Shenzhen Third People{\textquoteright}s Hospital and the Chinese Academy of Sciences (CAS) Institute of Microbiology. The conference provides the basis for networking and fostering of collaboration opportunities between researchers in Southeast Asia and the United States based on the scientific and interactive platform of the USJCMSP and takes place in the region on an annual basis. This report summarizes the discussions and conclusions from the conference. Funding Information: Acknowledgments: We would like to thank the local staff and the Chinese Academy of Sciences students who volunteered to support the conference organization, the Shenzhen Third People's Hospital, Institute of Microbiology, Chinese Academy of Sciences (IMCAS), the EID Scientific Planning Committee, USJCMSP panel/board chairs and members, moderators, rapporteurs, speakers, poster presenters, and all the participants for making this successful conference possible. In addition, we would like to thank the teams at the Japan Agency for Medical Research and Development, the Ministry of Foreign Affairs; the Ministry of Health, Labour, and Welfare; and the Ministry of Education, Culture, Sports, Science, and Technology and the United States National Institutes of Health for their continuous support. Publisher Copyright: {\textcopyright} 2019, MDPI AG. All rights reserved.",
year = "2019",
month = jun,
doi = "10.3390/vaccines7020035",
language = "English",
volume = "7",
journal = "Vaccines",
issn = "2076-393X",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "2",
}